Sep 26, 2023 11:01am EDT Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
Aug 30, 2023 8:19am EDT Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
Mar 28, 2023 9:09am EDT Todos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen Diagnostics
Mar 13, 2023 7:26pm EDT Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note Holders
Feb 14, 2023 9:06am EST Todos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista Diagnostics
Nov 29, 2022 8:23am EST Todos Medical’s 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022
